Adalta Capital Management’s Teladoc Health TDOC Stock Holding History

Adalta Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-675	Closed	-$22K	–	99
2022 Q2	$22K	Hold	675	–	–	0.01%	98
2022 Q1	$49K	Sell	675 -270	-29%	-$19.5K	0.02%	95
2021 Q4	$87K	Sell	945 -145	-13%	-$17.3K	0.04%	85
2021 Q3	$138K	Hold	1,090	–	–	0.08%	84
2021 Q2	$181K	Hold	1,090	–	–	0.1%	80
2021 Q1	$198K	Sell	1,090 -565	-34%	-$131K	0.11%	72
2020 Q4	$331K	Buy	1,655 +615	+59%	+$125K	0.21%	52
2020 Q3	$228K	Buy	+1,040	New	+$220K	0.17%	61
2020 Q2	–	Sell	-1,665	Closed	-$258K	–	72
2020 Q1	$258K	Sell	1,665 -1,185	-42%	-$138K	0.23%	51
2019 Q4	$239K	Sell	2,850 -1,000	-26%	-$76.1K	0.15%	61
2019 Q3	$261K	Sell	3,850 -1,500	-28%	-$98.7K	0.17%	69
2019 Q2	$355K	Buy	5,350 +780	+17%	+$45.5K	0.23%	62
2019 Q1	$254K	Buy	+4,570	New	+$279K	0.19%	63

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Adalta Capital Management's TDOC Position: Q3 2022 in Review

Adalta Capital Management sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 675 shares — an estimated $22K sold.

Adalta Capital Management first reported a position in TDOC in Q1 2019 and held it in 13 quarters. The position peaked at $355K in Q2 2019. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

Adalta Capital Management reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
Adalta Capital Management sold 675 Teladoc Health shares in Q3 2022, an estimated $22K.
Adalta Capital Management first reported a position in Teladoc Health in Q1 2019 and held it in 13 quarters.
Adalta Capital Management's Teladoc Health position peaked at $355K in Q2 2019.
483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Adalta Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.